Hepatobiliary effects and safety of tirzepatide: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Hepatobiliary effects and safety of tirzepatide: A systematic review and meta‐analysis

Published:2024-09-13 Issue: Volume: Page:
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Kamrul‐Hasan A. B. M.¹^ORCID,Dutta Deep²^ORCID,Nagendra Lakshmi³^ORCID,Kuchay Mohammad Shafi⁴^ORCID,Islam Md. Saiful⁵^ORCID,Pappachan Joseph M.⁶^ORCID

Affiliation:

1. Department of Endocrinology Mymensingh Medical College Mymensingh Bangladesh

2. Department of Endocrinology CEDAR Superspeciality Healthcare New Delhi India

3. Department of Endocrinology, JSS Medical College JSS Academy of Higher Education and Research Mysore India

4. Department of Endocrinology and Diabetes Medanta the Medicity Hospital Gurugram India

5. Department of Hepatology Bangabandhu Sheikh Mujib Medical University Dhaka Bangladesh

6. Department of Endocrinology and Metabolism Lancashire Teaching Hospitals NHS Trust & Manchester Metropolitan University Preston UK

Publisher

Wiley

Reference12 articles.

1. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives

2. Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?

3. A meta‐analysis of the effects of glucagon‐like‐peptide 1 receptor agonist (GLP1‐RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D);Ghosal S;Sci Rep,2021

4. Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis

5. Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)